Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies

Go back to Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
(NASDAQ: CELU) Delayed: 0.74 +0.01 (1.37%)
Previous Close $0.73    52 Week High
Open $0.74    52 Week Low
Day High $0.74    P/E N/A 
Day Low $0.73    EPS
Volume 4,176       

(NASDAQ: CELU) Delayed: 0.74 +0.01 (1.37%)
Previous Close $0.73    52 Week High
Open $0.74    52 Week Low
Day High $0.74    P/E N/A 
Day Low $0.73    EPS
Volume 4,176